These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9766900)

  • 1. Effect of glucantime on field and patient isolates of New World Leishmania: use of growth parameters of promastigotes to assess antimony susceptibility.
    Moreira ES; Anacleto C; Petrillo-Peixoto ML
    Parasitol Res; 1998 Sep; 84(9):720-6. PubMed ID: 9766900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucantime susceptibility of Leishmania promastigotes under variable growth conditions.
    Moreira ES; Soares RM; Petrillo-Peixoto Mde L
    Parasitol Res; 1995; 81(4):291-5. PubMed ID: 7624285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucantime resistant Leishmania promastigotes are sensitive to pentostam.
    Moreira ES; Guerra JB; Petrillo-Peixoto Mde L
    Rev Soc Bras Med Trop; 1992; 25(4):247-50. PubMed ID: 1340539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania (V.) guyanensis: isolation and characterization of glucantime-resistant cell lines.
    Ferreira-Pinto KC; Miranda-Vilela AL; Anacleto C; Fernandes AP; Abdo MC; Petrillo-Peixoto ML; Moreira ES
    Can J Microbiol; 1996 Sep; 42(9):944-9. PubMed ID: 8864217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of meglumine antimoniate, a pentavalent antimonial drug, on Leishmania promastigotes.
    Moreira ES; Petrillo-Peixoto ML
    Braz J Med Biol Res; 1991; 24(5):459-69. PubMed ID: 1823261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of Leishmania viannia panamensis to pentavalent antimony is correlated with the formation of cleavable DNA-protein complexes.
    Lucumi A; Robledo S; Gama V; Saravia NG
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1990-5. PubMed ID: 9687395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
    Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
    J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity to Glucantime of Leishmania viannia isolated from patients prior to treatment.
    Robledo SM; Valencia AZ; Saravia NG
    J Parasitol; 1999 Apr; 85(2):360-6. PubMed ID: 10219320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: Antimony resistance in human isolates from atypical lesions.
    Rugani JN; Quaresma PF; Gontijo CF; Soares RP; Monte-Neto RL
    Biomed Pharmacother; 2018 Dec; 108():1170-1180. PubMed ID: 30372818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.
    Grogl M; Thomason TN; Franke ED
    Am J Trop Med Hyg; 1992 Jul; 47(1):117-26. PubMed ID: 1322070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis.
    Morais-Teixeira Ed; Carvalho AS; Costa JC; Duarte SL; Mendonça JS; Boechat N; Rabello A
    Mem Inst Oswaldo Cruz; 2008 Jun; 103(4):358-62. PubMed ID: 18660990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface carbohydrates and in vivo infectivity of glucantime-sensitive and resistant Leishmania (Viannia) guyjanensis cell lines.
    Gazola KC; Ferreira AV; Anacleto C; Michalick MS; Andrade AF; Moreira ES
    Parasitol Res; 2001 Nov; 87(11):935-40. PubMed ID: 11728019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B.
    Zauli-Nascimento RC; Miguel DC; Yokoyama-Yasunaka JK; Pereira LI; Pelli de Oliveira MA; Ribeiro-Dias F; Dorta ML; Uliana SR
    Trop Med Int Health; 2010 Jan; 15(1):68-76. PubMed ID: 19874570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia.
    Fernández OL; Diaz-Toro Y; Ovalle C; Valderrama L; Muvdi S; Rodríguez I; Gomez MA; Saravia NG
    PLoS Negl Trop Dis; 2014 May; 8(5):e2871. PubMed ID: 24853871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional analysis of an amplification containing a PGPA gene in a glucantime-resistant Leishmania (Viannia) guyanensis cell line.
    Anacleto C; Abdo MC; Ferreira AV; Murta SM; Romanha AJ; Fernandes AP; Moreira ES
    Parasitol Res; 2003 Jun; 90(2):110-8. PubMed ID: 12756544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility.
    Barrera MC; Rojas LJ; Weiss A; Fernandez O; McMahon-Pratt D; Saravia NG; Gomez MA
    Acta Trop; 2017 Dec; 176():355-363. PubMed ID: 28843396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.
    Ephros M; Bitnun A; Shaked P; Waldman E; Zilberstein D
    Antimicrob Agents Chemother; 1999 Feb; 43(2):278-82. PubMed ID: 9925518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites.
    Hadighi R; Mohebali M; Boucher P; Hajjaran H; Khamesipour A; Ouellette M
    PLoS Med; 2006 May; 3(5):e162. PubMed ID: 16605301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of tryparedoxin peroxidase (TryP) and trypanothione reductase (TryR) in antimony unresponsive of Leishmania tropica clinical isolates of Iran.
    Nateghi-Rostami M; Tasbihi M; Darzi F
    Acta Trop; 2022 Jun; 230():106392. PubMed ID: 35276060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approach to in vitro drug susceptibility assessment of clinical strains of Leishmania spp.
    Fernández O; Diaz-Toro Y; Valderrama L; Ovalle C; Valderrama M; Castillo H; Perez M; Saravia NG
    J Clin Microbiol; 2012 Jul; 50(7):2207-11. PubMed ID: 22518860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.